## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `article_bundle` — **LLM article bundle**
Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution.
- **article slug:** `pt-141-ibd`
- **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest
- **how to use:** Reference block for Grok/GPT/Gemini. Section §SELF explains the system.
- **read:** https://miscsubjects.com/api/articles/pt-141-ibd/bundle?format=markdown

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/pt-141-ibd/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/pt-141-ibd/topology
- **voxels** — Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance. · https://miscsubjects.com/api/articles/pt-141-ibd/voxels
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/pt-141-ibd/prompts
- **ingest** — Parse pasted evidence → source ledger + claims + evidence_ingest node.
- **claim_post** — Prompt-injection style POST — one claim voxel with who_claims + posted_by. · https://miscsubjects.com/api/articles/pt-141-ibd/voxels
- **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*

---

# miscsubjects article bundle

> Reference bundle for Grok, GPT, Gemini, or a human reader. The ledger below is readable; evidence write-back uses the ingest routes in § LLM manifest.

## MASTHEAD
- **identity:** `pt-141-ibd` v2 · content_hash `9a90d9b180057d81…` · thread_head genesis · 20 DIVs
- **thesis (c1):** No human trials test PT-141 in IBD patients.
  - c2 [preclinical/active] A 2023 review examined melanocortin system effects in mouse colitis models but did not test PT-141.
  - c3 [mechanistic/active] PT-141 primary actions center on CNS melanocortin receptors for arousal rather than gut tissue repair.
- **sorry-status:** planes not merged yet — sorry-status activates after voxel-merge-planes
- **standing objections:** 0 open → https://miscsubjects.com/api/articles/pt-141-ibd/discourse
- **verbs:** read free · challenge/attest open · edit/move/consolidate CAS-gated with a rows:VOXEL_* key
- **reads_next:** https://miscsubjects.com/a/philosophy · https://miscsubjects.com/api/articles/pt-141-ibd/discourse · https://miscsubjects.com/api/protocol

## Article
- **slug:** `pt-141-ibd`
- **title:** PT-141 for IBD (Crohn's / Colitis): Evidence Review
- **url:** https://miscsubjects.com/a/pt-141-ibd
- **register:** source_ledger
- **updated:** 2026-07-17T02:41:06.983Z
- **tags:** peptide, matrix

## Body

## What's breaking down if you have IBD (Crohn's / colitis)

IBD involves ongoing gut lining damage. The intestinal barrier loses integrity. Immune cells release excess inflammatory signals. Tissue repair lags behind repeated injury. This cycle keeps symptoms active.

Layers include epithelial breakdown, cytokine imbalance favoring inflammation, and disrupted mucosal healing. Mechanical or symptom-masking approaches may ease pressure short-term but do not address the core repair deficit.

## Why PT-141 might help you

1. You are reading about IBD (Crohn's / colitis) — what breaks down matters before any compound name.
2. Therefore for you: If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.

PT-141 acts on melanocortin receptors in the central nervous system and periphery. If melanocortin pathways influence gut inflammation or repair signals in your case, the compound could intersect those routes. This remains a mechanistic link only. No direct mapping to IBD symptom relief exists in studied data.

## How these fit together

Single-compound focus — PT-141 targets sexual / CNS arousal pathways. If your condition profile includes a multi-peptide stack, siblings would target other layers such as direct tissue repair or inflammation modulation. PT-141 stands alone here because its documented actions center on arousal circuits rather than primary gut repair.

## What the evidence actually shows

No human trials test PT-141 in IBD patients (human tier: absent). No rat or mouse studies administer PT-141 in colitis models (preclinical tier: absent for this peptide). A 2023 review examined the broader melanocortin system in IBD using mouse colitis models and noted potential anti-inflammatory roles for related peptides such as α-MSH and KPV (preclinical tier: melanocortin system in general). PT-141 itself receives no mention (source status: unsourced for direct link).

## What scientists say

Researchers describe melanocortin receptor activation as capable of down-regulating NF-κB and certain cytokines in inflamed gut tissue from animal work. They frame this as a possible future direction, not a current therapy. No statements link PT-141 specifically to IBD repair or suppression (mechanistic tier).

## What people say on Reddit

Anecdotal reports of PT-141 use center on sexual function. No widespread IBD-specific threads appear in searched discussions. Isolated mentions treat it as unrelated to bowel inflammation (anecdotal tier: none found).

## What people say on X

Posts discuss PT-141 for arousal or libido. No posts connect it to Crohn's or colitis outcomes. Searches return zero relevant patient experiences (anecdotal tier: none found).

## What we do not know

Whether PT-141 crosses into gut repair pathways at meaningful levels in humans remains unknown. Long-term effects on intestinal inflammation lack any data. Interactions with standard IBD therapies stay unexamined. Human safety in active IBD patients is untested.

## Safety and limits

PT-141 carries documented side effects including nausea and flushing from its approved use in sexual dysfunction. Any extension to IBD would require separate safety evaluation. Current evidence supplies no basis for expecting benefit or ruling out harm in this context (speculative tier for IBD application).

## Claims (3)

- **c1** [human w=0.8] No human trials test PT-141 in IBD patients.
  - who_claims: grok/grok-4.3
  - sources: s1
- **c2** [preclinical w=0.5] A 2023 review examined melanocortin system effects in mouse colitis models but did not test PT-141.
  - who_claims: grok/grok-4.3
  - sources: s2, s1
- **c3** [mechanistic w=0.3] PT-141 primary actions center on CNS melanocortin receptors for arousal rather than gut tissue repair.
  - who_claims: grok/grok-4.3
  - sources: s3

## Voxel graph (3 atoms · 7 edges)
- full graph: https://miscsubjects.com/api/articles/pt-141-ibd/voxels

## Article constitution

- full: https://miscsubjects.com/api/articles/constitution

## Source ledger (3)
- chain valid: yes · head: `f38dd572a4507d68`

### s1 · review · ok
- title: The Melanocortin System in Inflammatory Bowel Diseases: Insights into Its Mechanisms and Therapeutic Potentials
- url: https://pmc.ncbi.nlm.nih.gov/articles/PMC10378568/
- summary: 2023 review of melanocortin system in IBD; mouse models only; no PT-141 data.
- quote: This review summarises the evidence acquired so far and highlights that molecules interfering with the melanocortin system could represent new drugs for treating IBD.
- claim_ids: c1, c2
- hash: `4b10cbaacb4afae1`

### s2 · pubmed · ok
- title: The Melanocortin System in Inflammatory Bowel Diseases
- url: https://pubmed.ncbi.nlm.nih.gov/37508552/
- summary: Confirms preclinical focus on related melanocortin peptides, not PT-141.
- quote: In the latter context, the system has assumed importance in conditions of chronic digestive inflammation, such as inflammatory bowel diseases (IBD), in which numerous experiences have been accumulated in mouse models of colitis.
- claim_ids: c2
- hash: `8cdf0972935b49f8`

### s3 · medical · http_403
- title: Bremelanotide (subcutaneous route)
- url: https://www.mayoclinic.org/drugs-supplements/bremelanotide-subcutaneous-route/description/drg-20466805
- summary: Official indication confirms CNS/arousal focus.
- quote: Bremelanotide injection is used to treat hypoactive sexual desire disorder (HSDD) in premenopausal women who previously had no problems with sexual desire.
- claim_ids: c3
- hash: `f38dd572a4507d68`

## Provenance (2 model passes)
- chain valid: yes · head: `a2b2a868067baf7e`

- write · grok/grok-4.3 · 2026-06-30T01:15 · hash `9a072c08d00f`
- voxel_divide · owner · 2026-07-17T02:41 · hash `a2b2a868067b`

## Question graph
- questions: 0 · evidence ingests: 0

## LLM manifest — how to communicate with this ledger

- system map: https://miscsubjects.com/api/articles/system-map?format=markdown
- topology (ranked): https://miscsubjects.com/api/articles/pt-141-ibd/topology
- ingest: POST https://miscsubjects.com/api/protocol/ingest
- claim: POST https://miscsubjects.com/api/protocol/claim

### Quick actions for this article
- **Read live:** https://miscsubjects.com/api/articles/pt-141-ibd/topology
- **Ask (API):** POST https://miscsubjects.com/api/protocol/ask `{"slug":"pt-141-ibd","question":"..."}`
- **Ingest your findings:** POST https://miscsubjects.com/api/protocol/ingest or text `ingest pt-141-ibd|your evidence`
- **Post one claim:** POST https://miscsubjects.com/api/protocol/claim or text `claim pt-141-ibd|tier|assertion`
- **iMessage ask:** `pt-141-ibd|your question`
- **System map:** https://miscsubjects.com/api/articles/system-map?format=markdown


---

## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `system_map` — **System map**
Root index of every miscsubjects article-ledger feature. Start here if you have zero context.
- **article slug:** `pt-141-ibd`
- **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest
- **how to use:** Root index of every miscsubjects article-ledger feature. Start here if you have zero context.
- **read:** https://miscsubjects.com/api/articles/system-map

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/pt-141-ibd/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **constitution** — Binding rules: required article slots, claim/source rules, ontology anti-sprawl. · https://miscsubjects.com/api/articles/constitution
- **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest
- **oip_article_hub** — Public article-native Object Invocation Protocol docs: /a/oip root, generated shelf/system/capability articles, machine bundles, token boundary, and receipt loop. · https://miscsubjects.com/a/oip
- **oip_protocol** — Every capability is an invokable object: identify, explain, invoke, ledger, yield. · https://miscsubjects.com/a/oip
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/pt-141-ibd/bundle?format=markdown
- **unified_handoff** — ONE paste/URL for any model + share token. Same self-explaining pattern as article bundle, but whole build. · https://miscsubjects.com/api/handoff?format=markdown

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*